RecruitingNCT06952452
Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)
PHASE3 · 630 planned enrolment
- Countries listed
- 1
- Registry update
- November 20, 2025
Registry Intervention View
Ranibizumab Ophthalmic
Trial registrations containing the exact intervention label Ranibizumab Ophthalmic.
Exact registry label · Not reported
2 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
1 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT00764738
Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration
PHASE2 · PHASE3 · 91 planned enrolment
- Countries listed
- 1
- Registry update
- September 22, 2020